Center-Authored Papers

Filters: Author is Vicini, Paolo  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Seng K-Y, Glenny RW, Madtes DK, Spilker ME, Vicini P, Gharib SA.  2008.  Comparison of statistical data models for identifying differentially expressed genes using a generalized likelihood ratio test.. Gene regulation and systems biology :. 2:125-139. Abstract
2009
Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
2010
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
2012
Li H, Mager DE, Bemer MJ, Salinger DH, Vicini P, Sandmaier BM, Nash R, McCune JS.  2012.  A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.. Journal of clinical pharmacology. 52(11):1654-64. Abstract
Adolescent
McCune JS, Vicini P, Salinger DH, O'Donnell PV, Sandmaier BM, Anasetti C, Mager DE.  2015.  Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.. Cancer chemotherapy and pharmacology. 75(1):67-75. Abstract
Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
Adult
McCune JS, Vicini P, Salinger DH, O'Donnell PV, Sandmaier BM, Anasetti C, Mager DE.  2015.  Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.. Cancer chemotherapy and pharmacology. 75(1):67-75. Abstract
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
Aged
Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
McCune JS, Vicini P, Salinger DH, O'Donnell PV, Sandmaier BM, Anasetti C, Mager DE.  2015.  Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.. Cancer chemotherapy and pharmacology. 75(1):67-75. Abstract
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Ambulatory Care Facilities
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Antimetabolites, Research Trials Office Core Facility - Biostatistics Service, Antineoplastic
McCune JS, Vicini P, Salinger DH, O'Donnell PV, Sandmaier BM, Anasetti C, Mager DE.  2015.  Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.. Cancer chemotherapy and pharmacology. 75(1):67-75. Abstract
Antineoplastic Agents, Alkylating
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Area Under Curve
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Bayes Theorem
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Blood Specimen Collection
Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
Busulfan
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Center-Authored Paper
Salinger DH, Vicini P, Blough DK, O'Donnell PV, Pawlikowski MA, McCune JS.  2010.  Development of a population pharmacokinetics-based sampling schedule to target daily intravenous busulfan for outpatient clinic administration.. Journal of clinical pharmacology. 50(11):1292-300. Abstract
Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
Li H, Mager DE, Bemer MJ, Salinger DH, Vicini P, Sandmaier BM, Nash R, McCune JS.  2012.  A limited sampling schedule to estimate mycophenolic Acid area under the concentration-time curve in hematopoietic cell transplantation recipients.. Journal of clinical pharmacology. 52(11):1654-64. Abstract
Child
McCune JS, Vicini P, Salinger DH, O'Donnell PV, Sandmaier BM, Anasetti C, Mager DE.  2015.  Population pharmacokinetic/dynamic model of lymphosuppression after fludarabine administration.. Cancer chemotherapy and pharmacology. 75(1):67-75. Abstract
Salinger DH, Blough DK, Vicini P, Anasetti C, O'Donnell PV, Sandmaier BM, McCune JS.  2009.  A limited sampling schedule to estimate individual pharmacokinetic parameters of fludarabine in hematopoietic cell transplant patients.. Clinical cancer research : an official journal of the American Association for Cancer Research. 15(16):5280-7. Abstract
Clinical Research Division
Seng K-Y, Glenny RW, Madtes DK, Spilker ME, Vicini P, Gharib SA.  2008.  Comparison of statistical data models for identifying differentially expressed genes using a generalized likelihood ratio test.. Gene regulation and systems biology :. 2:125-139. Abstract